Ahmed et al. evaluated HER2-CAR T cell therapy for medulloblastoma (78), demonstrating that HER2-CAR T cells are able to target and kill HER2+ medulloblastoma cells in vitro and in an established medulloblastoma orthotopic xenogeneic SCID mouse model (78). The gene discussed is ERBB2; the disease is medulloblastoma.